| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217114 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 7 Pages |
Abstract
Cyclooxygenase-2 RS cell expression is an adverse independent prognostic factor in early HL. Radiation therapy overcomes the worse prognosis associated with COX-2 expression on RS cells, acting in a chemotherapy-independent way. Cyclooxygenase-2 RS cell expression may be useful for determining patient candidates with early HL to receive consolidation with RT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Francisco MD, Antonio MD, PhD, Jose MD, PhD, Rafael MD, Juan Fernando MD, PhD, Jordi MD, PhD, Marta MD, Cristina MD, Leyre MD, Ines MD, Paloma MD, Jaime MD, Joan MD, PhD,